On Monday, Old Baltimore Pike Apothecary and Smith’s Pharmacy II filed a class action lawsuit directed at 4 pharmacy benefit managers (PBMs) and GoodRx for their roles in manipulating prescription drug prices. In line with what most PBM opposers have relayed throughout the past few years, the plaintiffs argued that PBMs’ drug price fixing agreements have resulted in declining reimbursements, pharmacy shutdowns, and ultimately a decrease in the delivery of valued care for patients nationwide.
“Independent pharmacies are the backbone of our communities, providing essential health care services to millions of Americans,” said Greg Asciolla, chair of DiCello Levitt’s Antitrust and Competition Litigation Practice Group partnering with the plaintiffs.1 “GoodRx and these PBMs—4 of the largest in the United States—have not only hurt small businesses but also the patients who rely on them for their medications. We aim to hold them accountable for the considerable harm caused by their sophisticated price-fixing scheme.”
Key Takeaways
- Old Baltimore Pike Apothecary and Smith’s Pharmacy II filed a class action lawsuit for the role 5 major PBMs played in allegedly fixing drug prices.
- This is the third lawsuit in the past week where independent pharmacies have aimed to hold PBMs accountable.
- PBMs are alleged to have worked together to manipulate drug prices and require fees to be paid by the pharmacies with little to no reimbursement revenue to keep those businesses afloat.
The 4 PBMs included in the suit are CVS Caremark, Express Scripts, MedImpact Healthcare, and Navitus Health Solutions. These companies, and other PBMs aligned with major health care and pharmacy brands, have come under recent scrutiny because of their existence as “prescription drug middlemen,” dealing with pharmacies, insurers, and manufacturers to establish drug prices and access.
In this case particularly, Old Baltimore Pike Apothecary and Smith’s Pharmacy II came together to establish a lawsuit of their own. Old Baltimore Pike Apothecary is based in Pennsylvania and Smith’s Pharmacy II is in Providence, Rhode Island. This is the third PBM-directed lawsuit in the past 2 weeks after Minnesota-based Keaveny Drug and Michigan-based Community Care Pharmacy filed lawsuits last week.2
READ MORE: Texas Sues Multiple PBMs, Drug Manufacturers Over Inflated Insulin Prices
“The lawsuit claims that the defendants’ actions have harmed independent pharmacies and reduced competition in the market. The plaintiffs argue that the defendants’ price-fixing agreements have led to the closure of many independent pharmacies and negatively impacted the quality of care provided to patients,” read the DiCello Levitt news release.1
PBMs like CVS Caremark and Express Scripts have been usual suspects in recent litigation attempting to hold these middlemen accountable. However, according to the conditions of the pharmacies’ recent lawsuits, GoodRx has emerged as a key party responsible for PBM-exacerbated issues within the industry.
“The 3 lawsuits allege that, starting last year, the PBMs and GoodRx entered into agreements in which the PBMs would use GoodRx's software to compare all available discounts for all patients' generic drug prescriptions, and route each purchase through the PBM with the lowest price—even if it was different than the patient's PBM,” wrote Brendan Pierson for Reuters.2